Diabetes Clinical Trials in Cleveland

Showing 41-60 of 287 trials

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

NCT06046833

A pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes and gastroparesis and those with diabetes without gastroparesis.

Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Gastroparesis With Diabetes Mellitus

Samita Garg50 participantsStarted Jan 2024

Cleveland, Ohio, United States

COMPLETEDPHASE4< 1 mile

Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

NCT04538352

This study is designed to determine whether therapy with once-weekly sc semaglutide in combination with once-daily insulin degludec will be capable of maintaining (or improving) glycemic control, when substituted for multiple daily injections of insulin (MDI), in patients with T2D with adequate glycemic control (≤ 7.5%) on MDI-based regimens (≤ 80 units of insulin per day), vs. further titration of insulin therapy in those continuing MDI. Weight loss, hypoglycemic episodes, and improvement in diabetes-treatment satisfaction will also be assessed between the two groups.

Type 2 Diabetes

The Cleveland Clinic60 participantsStarted Jan 2021

Cleveland, Ohio, United States

COMPLETEDNA< 1 mile

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

NCT05714059

The purpose of this study is to confirm the safety and effectiveness of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 diabetes adult and pediatric subjects in a home setting.

Type 1 Diabetes

Medtronic Diabetes250 participantsStarted Feb 2023

Little Rock, Arkansas, United States • Palo Alto, California, United States • San Francisco, California, United States +20 more locations

Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes

Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Diabetes Trials in Other Cities

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

MIRACLE of LIFE Study

C-myc Biomarker Study for Diabetic Foot Ulcers

VasQ External Support for Arteriovenous Fistula

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

Longitudinal Observation of Insulin Requirements and Sensor Use in Pregnancy

A Study of Autologous Renal Autologous Cell Therapy (REACT) in Patients With Diabetic Chronic Kidney Disease

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Diabetes Pump With Predictive Low Glucose Suspend Pivotal Trial

Other Conditions in Cleveland